President & CEO Brian Lian Sells 35,000 Shares of Viking Therapeutics Inc
Brian Lian, President & CEO of Viking Therapeutics Inc, executed a sale of 35,000 shares in the company on January 30, 2024, according to a recent SEC Filing. Viking Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders.
The transaction was carried out at an average price of $23.95 per share, which resulted in a total value of $837,250. Following this transaction, the insider's stake in Viking Therapeutics Inc has been adjusted as per the latest filings.
Over the past year, the insider has sold a cumulative total of 349,336 shares of Viking Therapeutics Inc and has not made any purchases of the stock. The company's insider transaction history indicates a pattern of sales with 15 insider sells and no insider buys over the same timeframe.
On the date of the reported sale, Viking Therapeutics Inc's shares were trading at $23.95, giving the company a market capitalization of $2.382 billion.
The insider trends for Viking Therapeutics Inc suggest a one-sided transaction pattern from the insiders, with a notable absence of buy transactions over the past year. This could be of interest to current and potential investors as they evaluate the company's stock performance and insider confidence.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
